Back to CITADEL ADVISORS LLC CITADEL ADVISORS LLC

DFTXDFTX
2 quarters

Position history for CITADEL ADVISORS LLCCITADEL ADVISORS LLC's holdings in Definium Therapeutics, Inc.

CITADEL ADVISORS LLC holds 1.7M shares of DFTX (Definium Therapeutics, Inc.), worth $79.4M as of 2026-Q2. The position was increased (+26.6% shares). DFTX represents 0.0% of CITADEL ADVISORS LLC's portfolio.

Current Value

$79.4M

Current Shares

1.7M

Total Value Change

+$54.2M

Total Shares Change

+355,145

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
1.7M
+26.6%
$79.4M0.0%$47.04
37
2026-Q1
New
1.3M
-
$25.2M0.0%$17.69
40

Other major holders of DFTX: BlackRock, Inc., Avoro Capital Advisors LLC, DRIEHAUS CAPITAL MANAGEMENT LLC, Capital World Investors, FMR LLC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used